Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Excerpt | Reference |
|---|
| ""Outpatient hyperkalemia" is a new clinical syndrome in which high serum potassium levels (SK) are found in the outpatient condition returning toward normal without any specific treatment after admission to the hospital." | ( Boer, P; Dorhout Mees, EJ; Rado, JP; Simatupang, T, 1979) |
| "Hyperkalemia is common in metabolic acidosis and oliguric renal failure." | ( Burke, MD, 1978) |
| "The hyperkalemia is not considered to be the cause of the block, since the block persisted despite the lowering of the blood potassium level and the morphologic findings in this case are not found in hyperkalemia." | ( Bharati, S; de la Fuente, DJ; Freij, Y; Kallen, RJ; Lev, M, 1975) |
| "Hyperkalemia is a severe complication of end-stage renal failure." | ( Fellay, G; Mooser, V; Regamey, C, 1992) |
| "Hyperkalemia is commonly encountered in patients who receive a renal transplant and the immunosuppressive drug, cyclosporine." | ( Albert, S; Carlisle, EJ; Ethier, JH; Halperin, ML; Kamel, KS; Levin, A; Quaggin, S, 1992) |
| "Hyperkalemia is a frequent complication in very low birth weight infants." | ( Hayen, LK; Kilbride, HW; Meade, VM; Shaffer, SG; Warady, BA, 1992) |
| "Hyperkalemia is expected with large oral potassium ingestion; and the elevated CO2 was spurious, caused by the misreading of serum nitrates by the Ektachrom 700 system." | ( Mayer, AP; Sporer, KA, 1991) |
| "Drug-induced hyperkalemia is increasingly common and usually is caused by nonsteroidal anti-inflammatory drugs, angiotensin converting enzyme inhibitors, cyclosporine, or K-sparing diuretics." | ( Williams, ME, 1991) |
| "This hyperkalemia is independent of acid-base or hormonal mechanisms known to regulate extrarenal homeostasis of potassium, and is strictly correlated with a rise in plasma osmolality." | ( Andreucci, VE; Conte, G; Dal Canton, A; De Nicola, L; Esposito, C; Fuiano, G; Gigliotti, G; Imperatore, P; Memoli, B; Pisanti, N, 1990) |
| "Hypokalemia and hyperkalemia are common problems that may be artifactual, iatrogenic, or due to altered body homeostatic mechanisms." | ( Willard, MD, 1989) |
| "Hypokalemia and hyperkalemia are electrolyte abnormalities that confront the emergency physician daily." | ( Zull, DN, 1989) |
| "Hyperkalemia is known to occur with increased frequency in the patient with diabetes mellitus and in the elderly when agents that interfere with renal potassium excretion are employed, but the precise frequency has not been established." | ( Hollenberg, NK; Mickiewicz, C, 1989) |
| "If prevention of hyperkalemia is the goal, as it should be, the current widespread and indiscriminate use of potassium supplements and potassium-sparing diuretics will need to end." | ( Harrington, JT; Jennings, AE; Madias, NE; Ponce, SP, 1985) |
| "Hyperkalemia is a common cause of electrolyte induced cardiac conduction disturbance." | ( Dittrich, KL; Walls, RM, 1986) |
| "The acidosis and hyperkalemia are corrected by hydrochlorothiazide." | ( Amundson, D; Hsueh, WA; Licht, JH; Lombardo, JV, 1985) |
| "The pseudo-hyperkalemia is a biochemical abnormality suspected when the blood level of K is increased, contrasting with the absence of usual symptoms of hyperkalemia." | ( Dagher, G; Dupont, M; Enet-Renou, N; Mimran, A; Mirouze, J; Richard, JL, 1983) |
| "Hyperkalemia is a common and potentially dangerous condition in elderly patients." | ( Booth, J; Cain, M; McCarthy, PJ; Walmsley, RN; White, GH, 1984) |
| "Hyperkalemia is also seen in "voltage dependent" states such as following the administration of lithium and amiloride." | ( Better, OS, 1982) |
| "Hyperkalemia is produced by redistribution of cellular and extracellular potassium or by increased body potassium." | ( Bastl, CP; Jones, ER; Narins, RG; Rudnick, MR; Stom, MC, 1982) |
| "Most significant hyperkalemia is associated with renal impairment, either glomerular or tubular; hypokalemia in many instances is causally related to increased renal potassium losses." | ( Elms, JJ, 1982) |
| "Reversible hyperkalemia is a rarely reported side effect of TMP-SMX therapy attributed to TMP inhibition of potassium secretion in the distal renal tubule in a manner similar to the potassium sparing diuretic, amiloride." | ( Marinella, MA, 1995) |
| "Hyperkalemia is one of the frequent medical emergencies in patients with chronic renal failure (CRF)." | ( Chiang, SS; Huang, TP; Liou, HH; Wu, SC; Yang, WC, 1994) |
| "Severe hyperkalemia is one of the potentially dangerous effects of the ACE inhibitors." | ( Doman, K; Muhammedi, M; Perlmutter, JA; Puschett, JB, 1993) |
| "Hyperkalemia is a commonly encountered problem in dialysis patients with end-stage renal disease." | ( Abramovici, M; Desroches, L; Maesaka, JK; Mattana, J; Singhal, PC; Wagner, JD, 1993) |
| "Hyperkalemia is a life threatening emergency and warrants immediate treatment because of its deleterious cardiac consequences." | ( Harps, E; Kemper, MJ; Müller-Wiefel, DE, 1996) |
| "Hyperkalemia is the most frequent electrolyte abnormality found in whole organ transplant recipients receiving either cyclosporine (CsA) or tacrolimus (FK506)." | ( Abecassis, MM; Fryer, JP; Kaplan, B; Kaufman, DB; Stuart, FP; Wang, Z, 1996) |
| "A progressive hyperkalemia is observed as exercise intensity increases." | ( Casaburi, R; Stringer, WW; Wasserman, K; Zhang, YY, 1997) |
| "Hyperkalemia is a life-threatening electrolyte disturbance." | ( Fairweather, P; Jagoda, A; McCarty, M, 1998) |
| "Rebound hyperkalemia is a potential hazard of potassium administration and occurred in 42% of 24 episodes." | ( Crapo, LM; Foote, JA; Manoukian, MA, 1999) |
| "Drug-induced hyperkalemia is an important but often overlooked problem encountered commonly in clinical practice." | ( Hirsh MJ, MD; Oster HR, MD; Oster, MD; Preston, RA, 1998) |
| "Familial pseudohyperkalemia is a "leaky red blood cell" condition in which the cells show a temperature-dependent loss of potassium (K) from red blood cells when stored at room temperature, manifesting as apparent hyperkalemia." | ( Ajetunmobi, JF; Carella, M; Delaunay, J; Gasparini, P; Iolascon, A; Perrotta, S; Stewart, GW; Zelante, L, 1999) |
| "However, hyperkalemia is generally neither severe nor prolonged, in which replacement therapy with mineralocorticoid is seldom necessary." | ( Inoue, D; Koshiyama, H; Muramatsu, Y; Sasano, H; Sato, Y; Sugawa, A; Tanaka, S; Taniguchi, R; Yamauchi, M, 1998) |
| "Hyperkalemia is a leading complication of the potassium-sparing agents, especially in patients with an underlying tendency for hyperkalemia." | ( Greenberg, A, 2000) |
| "Hyperkalemia is a serious electrolyte disorder and is a frequent finding in renal transplant recipients." | ( Akoglu, E; Bihorac, A; Kantarci, G; Koç, M; Ozener, CI, 2000) |
| "Hyperkalemia is a regularly encountered electrolyte abnormality." | ( Hughes, KM; Johnson, CM, 2001) |
| "Hyperkalemia is widely viewed as a common complication of ACE inhibition in azotemic patients." | ( Baigorria, ST; García, NH; Juncos, LI, 2001) |
| "Hyperkalemia is a common feature of chronic renal insufficiency, usually ascribed to impaired K+ homeostasis." | ( Gennari, FJ; Segal, AS, 2002) |
| "Pseudohyperkalemia is defined as a serum potassium concentration 0." | ( Fujigaki, Y; Fukasawa, H; Furuya, R; Hishida, A; Kato, A; Yamamoto, T; Yonemura, K, 2002) |
| "Hyperkalemia is a potentially life-threatening electrolyte disorder that may require immediate treatment." | ( Brouwer, RM; Trof, RJ, 2004) |
| "Hyperkalemia is a known side effect during treatment with Angiotensin Converting Enzyme Inhibitors (ACEIs)." | ( Dworkin, L; Yango, A; Zanabli, AR, 2004) |
| "Hypokalemia and hyperkalemia are among the most common disturbances of the electrolyte status." | ( Becker, B; Bergner, R; Lenz, T, 2004) |
| "Modest hyperkalemia is common with angiotensin-converting enzyme inhibition." | ( Bosch, J; Dagenais, GR; Gerstein, HC; Lonn, EM; Mann, JF; Sleight, P; Yi, QL, 2005) |
| "Acute hyperkalemia is a frequent and potentially life-threatening medical problem in patients on maintenance hemodialysis therapy." | ( Cronin, D; Kraus, MA; Mueller, BA; Sowinski, KM, 2005) |
| "Hyperkalemia is less common but more serious, especially if levels are rising rapidly." | ( Schaefer, TJ; Wolford, RW, 2005) |
| "Hyperkalemia is a life-threatening emergency that requires immediate therapy." | ( Daul, A; Nürnberger, J; Philipp, T, 2005) |
| "Hyperkalemia is a complications of the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists." | ( Kauffmann, R; Orozco, R; Venegas, JC, 2005) |
| "Pseudohyperkalemia is an elevation in measured serum or plasma potassium levels caused by mechanical release of potassium from cells during phlebotomy or specimen processing." | ( Kellerman, PS; Thornbery, JM, 2005) |
| "Hyperkalemia is a potentially life-threatening disorder frequently occurring in hospitalized patients." | ( Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J, 2007) |
| "The definition of hyperkalemia is important when evaluating its incidence in clinical trials." | ( Bourassa, MG; de Denus, S; Ducharme, A; Levesque, S; Racine, N; Tardif, JC; White, M, 2006) |
| "Furthermore, hyperkalemia is an adverse drug reaction of inhibitors of the renin-angiotensin system (RAS) that are established to be efficacious in these patients." | ( Mori, Y; Takaichi, K; Takemoto, F; Ubara, Y, 2007) |
| "The risk of hyperkalemia is increased in symptomatic heart failure patients with advanced age, male gender, baseline hyperkalemia, renal failure, diabetes, or combined RAAS blockade." | ( Desai, AS; Dunlap, ME; Granger, CB; Hainer, JW; McMurray, JJ; Michelson, EL; Olofsson, B; Pfeffer, MA; Solomon, SD; Swedberg, K; Young, JB; Yusuf, S, 2007) |
| "Hyperkalemia is one of the few potentially lethal electrolyte disturbances." | ( Weisberg, LS, 2008) |
| "In overdose, hyperkalemia is common." | ( Levine, M; Nikkanen, H; Pallin, DJ, 2011) |
| "Acute hyperkalemia is a frequent, potentially life-threatening complication in orthotopic liver transplantation (OLT)." | ( Chang, SH; Kim, DK; Kwon, WK; Woo, NS; Yun, IJ, 2009) |
| "Hyperkalemia is a potential threat to patient safety in chronic kidney disease (CKD)." | ( Einhorn, LM; Fink, JC; Hsu, VD; Moen, MF; Seliger, SL; Walker, LD; Weir, MR; Zhan, M, 2009) |
| "The risk of hyperkalemia is increased with CKD, and its occurrence increases the odds of mortality within 1 day of the event." | ( Einhorn, LM; Fink, JC; Hsu, VD; Moen, MF; Seliger, SL; Walker, LD; Weir, MR; Zhan, M, 2009) |
| "Hyperkalemia is exacerbated by angiotensin converting enzyme inhibitors (ACE-I)." | ( Bhandari, S; Garthwaite, E, 2009) |
| "Hyperkalemia is a common life-threatening problem in hemodialysis patients." | ( Dick, B; Farese, S; Frey, BM; Frey, FJ; Kruse, A; Pasch, A; Uehlinger, DE, 2009) |
| "Hyperkalemia is an electrolyte abnormality that can lead to severe consequences." | ( Cox, Z; Finch, CK; Hudson, JQ; King, T; Wilson, NS, 2009) |
| "Hyperkalemia is a common condition encountered in medical and surgical patients." | ( Drolet, S; Morcos, MW; Trottier, V, 2009) |
| "Hyperkalemia is common in patients with ESRD and may contribute to mortality." | ( Bokhari, E; El Shahat, O; El-Sayed, H; Hamid, MH; Roujouleh, H; Saleh, A; Seddik, A; Sheikh, I; Siddiqi, N, 2009) |
| "Hyperkalemia is a frequent problem in patients with end stage renal disease (ESRD) on maintenance hemodialysis and is often attributed as a cause of deaths in these patients." | ( Abdelwhab, S; Ali, M; El Said, K; El-Sharkawy, M; El-Sharkay, M; Khedr, E, 2009) |
| "Hyperkalemia is a frequent problem in patients with end stage renal disease in Egypt." | ( Abdelwhab, S; Ali, M; El Said, K; El-Sharkawy, M; El-Sharkay, M; Khedr, E, 2009) |
| "The incidence of hyperkalemia is also increased in patients with HF or CKD (5% to 10%)." | ( Rolfe, M; Weir, MR, 2010) |
| "This hyperkalemia is rapidly corrected by reaccumulation of K+ into the muscle cells via Na+,K+ pumps, often leading to hypokalemia." | ( Clausen, T, 2010) |
| "Hyperkalemia is a common condition, particularly in the setting of renal dysfunction." | ( Anderson, SD; Bosse, GM; Platt, MA; Presley, MW, 2011) |
| "Pseudohyperkalemia is uncommon, but important." | ( Matsushita, K; Nomura, F; Sawabe, Y; Seimiya, M; Sogawa, K; Umemura, H; Yoshida, T, 2010) |
| "Hyperkalemia is the main potential side effect of eplerenone, especially when used in combination with other medications that can cause hyperkalemia." | ( Abuannadi, M; O'Keefe, JH, 2010) |
| "Hyperkalemia is a rare but treatable cause of acute flaccid paralysis that requires immediate treatment." | ( Anziska, Y; Gandhi, S; Nugent, K; Panichpisal, K, 2010) |
| "Hyperkalemia is a potentially life-threatening condition in which serum potassium exceeds 5." | ( Kemper, MJ; Lehnhardt, A, 2011) |
| "Hyperkalemia is a concern in heart failure (HF), especially in older patients with co-morbidities." | ( Brunner-La Rocca, HP; Burkard, T; Julius, B; Maeder, MT; Muzzarelli, S; Nietlispach, F; Pfisterer, ME; Rickli, H; Toggweiler, S, 2012) |
| "Hyperkalemia is mainly seen in the setting of impaired renal function." | ( Erdogan, HI; Gul, EE; Nikus, KC; Soylu, A; Yıldırım, O, 2012) |
| "In conclusion, hyperkalemia is encountered frequently in patients with established CVD who are taking antihypertensive drugs and is associated with increases in all-cause mortality and hospitalizations." | ( Banerjee, S; Brilakis, ES; Jain, N; Kotla, S; Little, BB; Reilly, RF; Weideman, RA, 2012) |
| "Hyperkalemia is a medical condition that requires immediate recognition and treatment to prevent the development of life-threatening arrhythmias." | ( Baker, SL; Bernard, AW; Chan, JS, 2012) |
| "Acute hyperkalemia is a life-threatening event and often occurs abruptly and without warning in the perioperative field." | ( Goetz, AE; Kiefmann, R; Nitzschke, R; Olotu, C, 2012) |
| "Severe hyperkalemia is a life threatening condition that can cause fatal rhythm disturbance and terminal heart arrest." | ( Berka, Z; Berkova, M; Topinkova, E, 2014) |
| "Severe hyperkalemia is common in patients with OHCA who have severe KD and should be considered during resuscitation for these patients." | ( Chang, YH; Chi, CH; Chiang, WC; Lin, CH; Tu, YF; Wu, SY, 2013) |
| "ADRs such as hyperkalemia are more likely to be associated with the use of high-dose TMP-SMX in the ambulatory setting." | ( Furrh, RZ; Gentry, CA; Nguyen, AT, 2013) |
| "Hyperkalemia is a potentially serious complication following adrenalectomy of aldosterone-producing adenomas (APA)." | ( Cheng, CJ; Chiang, WF; Lin, MY; Lin, SH; Sun, GH; Sung, CC; Wu, ST, 2013) |
| "Hyperkalemia is considered a medical emergency as it can result in severe disturbances in cardiac rhythm and death." | ( Cusi, C; Gomez, D; Martin, DP; Michler, R; Schechter, W; Tobias, JD, 2013) |
| "Hyperkalemia is a potentially dangerous electrolyte abnormality with a reported incidence of 1-10 % in hospitals." | ( Crul, M; Gombert-Handoko, KB; Haak, EA; Kuijvenhoven, MA, 2013) |
| "Hyperkalemia is common when spironolactone and angiotensin converting enzyme inhibitors (ACEls) or angiotensin receptor blockers (ARBs) are combined." | ( Chatsiricharoenkul, S; Monsomboon, A; Surabenjawong, U; Thunpiphat, N, 2013) |
| "Risk of hyperkalemia is chronic kidney disease, high serum potassium, and high spironolactone use." | ( Chatsiricharoenkul, S; Monsomboon, A; Surabenjawong, U; Thunpiphat, N, 2013) |
| "Hyperkalemia is a clinically important electrolyte imbalance in neonatal diarrheic calves that has previously been associated with skeletal muscle weakness and life-threatening cardiac arrhythmias." | ( Constable, PD; Knubben-Schweizer, G; Lorch, A; Lorenz, I; Sauter-Louis, C; Trefz, FM, 2013) |
| "Hyperkalemia is a potentially life-threatening electrolyte abnormality commonly seen in the emergency department (ED)." | ( Briggs, AL; Deal, LL, 2014) |
| "Hyperkalemia is commonly seen in the elderly and is occasionally fatal." | ( Gourineni, VC; Juvet, T; Ravi, S; Zarich, SW, 2013) |
| "Hyperkalemia is an electrolyte disorder that may occur during the first few months after a renal transplant, in patients undergoing cyclosporine immunosuppression." | ( Ivanovski, N; Ivanovski, O; Masin-Spasovska, J; Pavleska-Kuzmanovska, S; Popov, Z; Rambabova-Busljetic, I; Ristovska, V, 2014) |
| "Hyperkalemia is a common and potentially lethal clinical problem." | ( Matuszkiewicz-Rowińska, J; Wojtaszek, E, 2013) |
| "Hyperkalemia is a common medical emergency that may result in serious cardiac arrhythmias." | ( Chothia, MY; Davids, MR; Halperin, ML; Hassan, MS; Rensburg, MA, 2014) |
| "The risk of hyperkalemia is linked to dietary potassium intake, level of kidney function, concomitant diseases that may affect potassium balance such as diabetes, and use of medications that influence potassium excretion." | ( Bakris, GL; Lazich, I, 2014) |
| "Hyperkalemia is a common clinical condition that can be defined as a serum potassium concentration exceeding 5." | ( Badreddine, A; Ben Salem, C; Fathallah, N; Hmouda, H; Slim, R, 2014) |
| "Severe hyperkalemia is a potentially life-threatening condition requiring immediate medical intervention." | ( Meng, QH; Wagar, EA, 2015) |
| "Hyperkalemia is a common electrolyte abnormality that may be difficult to manage because of a lack of effective therapies." | ( Kosiborod, M; Lavin, P; Lerma, E; Packham, D; Qunibi, WY; Rasmussen, HS; Roger, SD; Singh, B; Spinowitz, B; Yang, A, 2014) |
| "Hyperkalemia is an infrequent but potentially serious complication of low molecular weight heparin (LMWH) use." | ( Bramlage, P; Melzer, N; Michaelis, HC, 2014) |
| "Hyperkalemia is a clinically important electrolyte abnormality that occurs most commonly in patients with chronic kidney disease." | ( Kovesdy, CP, 2015) |
| "Hyperkalemia is a potentially life-threatening condition predominantly seen in patients treated with renin-angiotensin-aldosterone system (RAAS) inhibitors with stage 3 or greater chronic kidney disease (CKD) who may also have diabetes, heart failure, or both." | ( Bakris, GL; Berman, L; Bushinsky, DA; Freeman, MW; Garza, D; Mayo, MR; Pitt, B; Stasiv, Y; Weir, MR; Zawadzki, R, 2015) |
| "Hyperkalemia is defined as serum potassium concentrations elevated above the upper limit of normal (> 5." | ( Costanzo, MR; Lepor, NE; McCullough, PA; Silver, M; Spinowitz, B; Zhang, J, 2015) |
| "Hypokalemia and hyperkalemia are often noted in chronic kidney disease (CKD) patients, but their impact on mortality and end-stage renal disease (ESRD) is less well understood." | ( Arrigain, S; Huang, H; Jolly, SE; Nakhoul, GN; Nally, JV; Navaneethan, SD; Schold, JD, 2015) |
| "Hyperkalemia is a frequent electrolyte disorder associated with life-threatening cardiac arrhythmias and sudden death." | ( Bakris, GL; Georgianos, PI; Sarafidis, PA, 2015) |
| "Hyperkalemia is a potentially life-threatening condition that is common in kidney disease patients." | ( Pierce, DA; Pirkle, JL; Russell, G, 2015) |
| "Hyperkalemia is common in patients with impaired kidney function or who take drugs that inhibit the renin-angiotensin-aldosterone axis." | ( Ellison, DH; Gamba, G; Terker, AS, 2016) |
| "Hyperkalemia is a common problem in hospitalized patients, especially those with underlying chronic kidney disease, but evidence-based guidelines for its treatment are lacking." | ( Belz, MM; Farrington, CA; Hagan, AE; Wall, GC, 2016) |
| "Hyperkalemia is a potentially life-threatening condition, and patients who have chronic kidney disease, who are diabetic, or who are taking renin-angiotensin-aldosterone system inhibitors are at increased risk." | ( Benton, WW; Berman, L; Buysse, J; Cope, MJ; Harrison, SD; Lee, L; Li, L; Madsen, D; Park, C; Salaymeh, F, 2016) |
| "Hyperkalemia is a common electrolyte disorder that arises from dysfunctional homeostatic mechanisms or as a consequence of decreased renal function." | ( Kosiborod, M; Packham, DK, 2016) |
| "Hyperkalemia is a common clinical problem, especially in patients with chronic kidney disease, diabetes mellitus, or heart failure." | ( Alonso Garcia, Mde L; Bakris, GL; Berman, L; Butler, J; Epstein, M; Kosiborod, M; Mebazaa, A; Pitt, B; Rasmussen, HS; Rossignol, P; Ruilope, LM; Stockbridge, N; Stough, WG; Thompson, A; Wittes, J; Zannad, F, 2016) |
| "Hyperkalemia is a common electrolyte disorder that can result in fatal cardiac arrhythmias." | ( Harel, Z; Kamel, KS, 2016) |
| "Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease (CKD), diabetes mellitus, or heart failure, and is associated with a significantly increased risk for all-cause mortality." | ( Epstein, M; Pitt, B, 2016) |
| "Hyperkalemia is frequent, but occurs mostly in patients with chronic kidney disease and is often the cause of discontinuation or omission of renin-angiotensin-aldosterone system inhibitors in patients with diabetes, chronic kidney disease and heart failure." | ( Desforges, K; Lafrance, JP; Lepage, L, 2016) |
| "Hyperkalemia is common in patients receiving maintenance hemodialysis." | ( Hu, Y; Menoyo, JA; Singh, B; Wetmore, JB; Yusuf, AA, 2016) |
| "Hyperkalemia is commonly seen in patients with chronic kidney disease (CKD) and in patients on renin-angiotensin-aldosterone system (RAAS) inhibitors." | ( Nguyen, T; Pham, AQ; Rana, I; Sexton, J; Wimer, D, 2017) |
| "Hyperkalemia is a common electrolyte disorder, especially in chronic kidney disease, diabetes mellitus, or heart failure." | ( Emmett, M; Epstein, M; Gayat, E; Hollenberg, SM; Kosiborod, M; Kovesdy, CP; Legrand, M; Mebazaa, A; Peacock, WF; Pitt, B; Rossignol, P; Stough, WG; Yilmaz, MB; Zannad, F, 2016) |
| "Hyperkalemia is a common electrolyte disorder associated with life-threatening cardiac arrhythmias and increased mortality." | ( Krishnan, SK; Lepor, NE, 2016) |
| "Hyperkalemia is associated with adverse outcomes in patients with CKD and in hospitalized patients with acute medical conditions." | ( Beben, T; de Boer, IH; Deo, R; Homma, S; Hoofnagle, AN; Hughes-Austin, JM; Ix, JH; Katz, R; Kestenbaum, B; Psaty, BM; Rifkin, DE; Sarnak, MJ; Shlipak, MG; Siscovick, DS; Sotoodehnia, N, 2017) |
| "Reverse pseudohyperkalemia is a term used to describe in vitro, falsely elevated potassium concentrations in plasma specimens that occur in association with extreme leukocytosis and are commonly associated with hematologic malignant neoplasms." | ( Benirschke, RC; Lee, HK; Theparee, T, 2017) |
| "Acute hyperkalemia is a dangerous electrolyte disorder, which must be treated immediately." | ( Groene, P; Hoffmann, G, 2017) |
| "Hyperkalemia is prevalent in end-stage renal disease patients, being involved in life-threatening arrhythmias." | ( Fukami, K; Ito, S; Kaida, Y; Kodama, G; Kurokawa, Y; Minezaki, T; Moriyama, T; Nagata, A; Nakamura, N; Nakayama, Y; Shibatomi, K; Sugiyama, M; Taguchi, K; Ueda, K; Yamagishi, SI; Yano, J; Yoshida, C, 2018) |
| "Hyperkalemia is an important complication of adrenalectomy for patients with primary aldosteronism (PA)." | ( Fujii, Y; Fukuoka, T; Ichijo, T; Kai, T; Kamemura, K; Matsuda, Y; Naruse, M; Ogo, A; Sakamoto, R; Shibayama, Y; Suzuki, T; Tsuiki, M; Umakoshi, H; Wada, N, 2017) |
| "Hypokalemia and hyperkalemia are the most common electrolyte disorders managed in the emergency department." | ( Ashurst, J; Kim, J; Sergent, SR; Wagner, BJ, 2016) |
| "Although hyperkalemia is a well-recognized complication of CKD, the prevalence rates of hyperkalemia (14%-20%) and hypokalemia (12%-18%) are similar." | ( Gilligan, S; Raphael, KL, 2017) |
| "Hyperkalemia is a common complication in patients with heart failure or chronic kidney disease, particularly those who are taking inhibitors of the renin-angiotensin-aldosterone system." | ( Blanks, RC; Caldwell, JS; Davidson, JP; Jacobs, JW; King, AJ; Korner, P; Kumaraswamy, P, 2018) |
| "Hyperkalemia is a common electrolyte disorder that can result in morbidity and mortality if not managed appropriately." | ( Koyfman, A; Long, B; Warix, JR, 2018) |
| "Hyperkalemia is usually detected via serum clinical laboratory measurement." | ( Koyfman, A; Long, B; Warix, JR, 2018) |
| "PRIS causing hyperkalemia is a well-known clinical entity." | ( El-Ali, IM; Onuchic, A; Trivedi, RD; Virmani, S, 2016) |
| "Hyperkalemia is associated with severe clinical outcomes and death in HF." | ( Adelborg, K; Egfjord, M; Egstrup, K; Garcia-Sanchez, R; Hasvold, P; Nicolaisen, SK; Pedersen, L; Sørensen, HT; Thomsen, RW, 2018) |
| "Chronic hyperkalemia is a major complication of chronic kidney disease (CKD) that occurs frequently, heralds poor prognosis, and necessitates careful management by the nephrologist." | ( Bianchi, S; Cupisti, A; De Nicola, L; Di Lullo, L; Paoletti, E, 2018) |
| "Hyperkalemia is one of the most common electrolyte disturbances, especially among some groups of patients, such as in those with chronic kidney disease, diabetes or heart failure." | ( Cases, A; Gorriz, JL, 2018) |
| "Hyperkalemia is a risky and potentially life-threatening condition in pre-term infants." | ( Chen, JY; Chiu, CD; Chiu, YP; Ji, HR; Saw, HP, 2019) |
| "Hyperkalemia is an important clinical problem that is associated with significant lifethreatening complications." | ( Athyros, VG; Karagiannis, A; Piperidou, A; Sachinidis, AG; Simoulidou, E; Stavropoulos, N; Zografou, I, 2018) |
| "Hyperkalemia is a serious complication in cirrhotic patients." | ( Cai, JJ; Han, T; Jiang, HQ; Wang, K, 2019) |
| "Hyperkalemia is a common problem in both inpatients and outpatients." | ( Kupferman, FE; Kupferman, JC; Wooten, JM, 2019) |
| "Hyperkalemia is a potentially life-threatening complication of chronic kidney disease (CKD)." | ( Bartosh, SM; Bowman, B; Paloian, NJ, 2019) |
| "Hyperkalemia is a common electrolyte abnormality that can lead to life-threatening cardiac arrhythmia." | ( Liu, M; Rafique, Z, 2019) |
| "Hyperkalemia is a common, potentially lethal clinical condition that accounts for a significant number of emergency department (ED) visits." | ( Fitter, S; Gabrielson, SW; Koyfman, A; Long, B; Moussavi, K, 2019) |
| "Hyperkalemia is a life-threatening condition requiring emergent therapy." | ( Fitter, S; Gabrielson, SW; Koyfman, A; Long, B; Moussavi, K, 2019) |
| "Hyperkalemia is known to develop in various conditions including vigorous physical exercise." | ( Bányász, T; Chen-Izu, Y; Hegyi, B; Izu, LT, 2019) |
| "Hyperkalemia is a potentially fatal electrolyte disorder, more commonly present when the potassium excretion capacity is imparied." | ( Lopes, MB; Pecoits-Filho, R; Rocha, PN, 2019) |
| "Hyperkalemia is efficiently treated by continuous renal replacement therapy using the dialysis mode." | ( Baud, FJ; Carli, P; Gault, P; Houzé, P; Lamhaut, L; Moreira, S; Raphalen, JH; Winchenne, A, 2020) |
| "BACKGROUND Hyperkalemia is an important cause of arrhythmias and a medical emergency that requires urgent treatment." | ( Avčin, S; Grosek, Š; Kavčič, A, 2019) |
| "Hyperkalemia is common and potentially life threatening." | ( Liu, M; Minard, CG; Peacock, WF; Rafique, Z; Staggers, KA, 2020) |
| "Hyperkalemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction because it limits the use of effective drugs." | ( Almenar-Bonet, L; Andrés-Novales, J; Barge-Caballero, E; Bayés-Genís, A; Bierge-Valero, D; Bover-Freire, R; Crespo-Leiro, MG; Dalmau González-Gallarza, R; de Juan-Bagudá, J; de la Fuente-Galán, L; Delgado-Jiménez, J; Epelde-Gonzalo, F; Escudero-González, A; Fernández-Vivancos Marquina, C; Gallego-Page, JC; García-Pinilla, JM; González-Costello, J; Lambert-Rodríguez, JL; Lara-Padrón, A; López-Fernández, S; Lund, LH; Maggioni, AP; Muñiz, J; Pascual-Figal, DA; Pérez-Ruiz, JM; Quiles-Granado, J; Ridocci-Soriano, F; Roig-Minguell, E; Sahuquillo-Martínez, A; Sanz-Julve, M; Segovia-Cubero, J; Torres-Calvo, F; Varela-Román, A, 2020) |
| "Although hyperkalemia is much more common in patients with chronic kidney disease (CKD), the reported frequency of hyperkalemia varies markedly across studies, primarily due to differences in the ascertainment of hyperkalemia and the severity of CKD." | ( Seliger, SL, 2019) |
| "Chronic hyperkalemia is often associated with impaired renal ability to excrete excessive potassium ions (K+)." | ( Bachmann, S; Mutig, K, 2019) |
| "Hyperkalemia is associated with an increased risk of death, and this is only in part explicable by hyperkalemia-induced cardiac arrhythmia." | ( Bailey, MA; Hunter, RW, 2019) |
| "Hyperkalemia is a common electrolyte disorder that may be rapidly life-threatening because of its cardiac toxicity." | ( Coutrot, M; Dépret, F; Legrand, M, 2019) |
| "Hyperkalemia is increasingly prevalent in the heart failure population as more people live with heart failure and comorbid conditions such as diabetes and chronic kidney disease." | ( Sanjanwala, R; Sidhu, K; Zieroth, S, 2020) |
| "Mild hyperkalemia is a common side effect of mineralocorticoid receptor antagonist (MRA) treatment of patients with primary aldosteronism (PA), which can be worsened by instructions to minimize salt intake." | ( Chrousos, GP; Fountoulakis, S; Kounadi, T; Markou, A; Papanastasiou, L; Piaditis, G; Voulgaris, N, 2020) |
| "Hyperkalemia is a frequent finding in patients with chronic kidney disease (CKD)." | ( Watanabe, R, 2020) |
| "Hyperkalemia is one of the most frequent side effects related to renin-angiotensin-aldosterone system (RAAS) inhibition, and can influence optimization of heart failure (HF) therapy." | ( Amato, L; Bellino, MC; Caldarola, P; Ciccone, MM; Gioia, MI; Grande, D; Iacoviello, M; Lisi, F; Massari, F; Parisi, G, 2020) |
| "The occurrence of hyperkalemia is common among outpatients with HF and it is the main cause of MRA withdrawal, which is associated with a worse prognosis." | ( Amato, L; Bellino, MC; Caldarola, P; Ciccone, MM; Gioia, MI; Grande, D; Iacoviello, M; Lisi, F; Massari, F; Parisi, G, 2020) |
| "Hyperkalemia is a frequent and sometimes life-threatening condition that may be associated with arrhythmia and cardiac dysfunction in patients with heart failure (HF)." | ( Klimenko, A; Marketou, M; Rakisheva, A; Troyanova-Shchutskaia, T; Vardas, P, 2020) |
| "Hyperkalemia is a chronic and life-threatening electrolyte disorder that affects millions of patients around the world with decreased kidney function, hypertension, and heart failure." | ( Colbert, GB; Lerma, EV; Patel, D, 2020) |
| "Hyperkalemia is a common electrolyte abnormality encountered post organ transplantation." | ( Fülöp, T; Hamrahian, SM, 2021) |
| "Hyperkalemia is a common and an important cause of death in maintenance hemodialysis patients." | ( Amdur, RL; Barrows, ED; Centron-Vinales, P; Kincaid, D; Muralidharan, J; Nobakht, E; Patel, SS; Paul, R; Raj, DS; Siddiqi, M, 2020) |
| "Hyperkalemia is associated with both CHF and CKD, which often leads to withdrawal of heart failure medications in clinical praxis." | ( Böhm, M; Dederer, J; Kindermann, I; Slawik, J, 2020) |
| "Hyperkalemia is a common electrolyte disorder observed in the emergency department." | ( Burdmann, EA; Clase, CM; Hemmelgarn, BR; Herzog, CA; Lindner, G; Małyszko, J; Nagahama, M; Pecoits-Filho, R; Rafique, Z; Rossignol, P; Singer, AJ, 2020) |
| "Hyperkalemia is associated with many chronic diseases and renin-angiotensin-aldosterone system inhibitor therapy." | ( Harada, H; Kashihara, N; Kim, H; Osonoi, T; Sarai, N; Shibagaki, Y; Yajima, T; Yamasaki, Y; Zhao, J, 2021) |
| "Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences." | ( Carrero, JJ; Clegg, DJ; Colbert, GB; Emmett, M; Fishbane, S; Hain, DJ; Lerma, E; Onuigbo, M; Palmer, BF; Rastogi, A; Roger, SD; Spinowitz, BS; Weir, MR, 2021) |
| "Hyperkalemia is a potentially life-threatening condition associated with the use of heart failure (HF) medications, which can lead to increased morbidity and mortality." | ( Calixto, CA; Contreras, JP; Gallo-Bernal, S; Medina, HM; Molano-González, N; Moreno, MPD; Rodríguez, MJ; Tamayo, MF, 2021) |
| "Hyperkalemia is an electrolyte disorder that frequently affects patients in the emergency department (ED), and can result in significant morbidity and mortality if not identified and treated rapidly." | ( Batard, E; Le Bastard, Q; Lemoine, L; Montassier, E, 2021) |
| "Hyperkalemia is a frequent electrolyte disorder in the ED." | ( Batard, E; Le Bastard, Q; Lemoine, L; Montassier, E, 2021) |
| "Hyperkalemia is common in medicine and requires rapid management." | ( Greffe, S; Hanslik, T; Jondeau, K; Kahn, JE; Le Goff, E; Ngo, S; Ronez, E; Venon, MD, 2021) |
| "Hyperkalemia is a rare life-threatening complication of red blood cell (RBC) transfusion." | ( Bahar, B; Delaney, M; Edelson, M; Lee, A; Saifee, NH; Yamada, C, 2021) |
| "Hyperkalemia is defined as blood potassium levels >5 mEq/L and evaluated based on the CKD, DM, HF medications, and New York Heart Association (NYHA) classes." | ( Çavuşoğlu, Y; Kaya, H; Murat, S; Yılmaz, MB, 2021) |
| "Severe hyperkalemia is also a potential cause, especially in elderly patients with impaired renal function." | ( Bianzina, S; Cipriani, L; D'Ercole, M; Esposito, P; Picciotto, D; Russo, E; Viazzi, F, 2021) |
| "Hyperkalemia is relatively frequent in CKD patients treated with renin-angiotensin-aldosterone-system inhibitors (RAASi)." | ( Alessandrini, D; Degli Esposti, L; Giacomini, E; Perrone, V; Sangiorgi, D; Santoro, A, 2022) |
| "Hyperkalemia is a challenging comorbidity to manage in patients with heart failure and chronic kidney disease, particularly when administering renin-angiotensin-aldosterone system inhibitors." | ( Imamura, T; Kinugawa, K; Narang, N; Oshima, A; Ueno, H; Ueno, Y; Ushijima, R, 2021) |
| "Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke." | ( Akbilgic, O; Dashputre, AA; Gatwood, J; Kalantar Zadeh, K; Kovesdy, CP; Molnar, MZ; Obi, Y; Potukuchi, PK; Streja, E; Sumida, K; Thomas, F, 2021) |
| "Hyperkalemia is a common and potentially life-threatening complication following kidney transplantation that can be caused by a composite of factors such as medications, delayed graft function, and possibly potassium intake." | ( Gabardi, S; Kalantar-Zadeh, K; Kovesdy, CP; Lazo, JG; Quan, D; Rizk, JG; Rizk, Y; Streja, E, 2021) |
| "While severe hyperkalemia is commonly encountered, its manifestation in hospitalized patients and related outcomes are unclear." | ( Gilbertson, DT; Herzog, CA; Peng, Y; Wetmore, JB; Yan, H, 2021) |
| "Hyperkalemia is an electrolyte disorder commonly encountered in the emergency department that can result in significant morbidity and mortality." | ( Geng, S; Green, EF; Kurz, MC; Rivera, JV, 2021) |
| "Hyperkalemia is associated with an increased risk of all-cause and CVD death, and this risk is more pronounced in patients with multiple risk factors." | ( Li, Y; Liu, J; Liu, S; Qi, Y; Sun, J; Wang, M; Zhao, D, 2022) |
| "Hyperkalemia is a common electrolyte abnormality in heart failure (HF) that can cause potentially life-threatening cardiac arrhythmias and sudden cardiac death." | ( Altay, H; Çavuşoğlu, Y; Çelik, A; Demir, Ş; Kılıçarslan, B; Nalbantgil, S; Temizhan, A; Tokgöz, B; Ural, D; Yeşilbursa, D; Yıldırımtürk, Ö; Yılmaz, MB, 2021) |
| "Hyperkalemia is a common electrolyte disorder in patients with chronic kidney disease, and can be life-threatening in severe cases." | ( Liu, DW; Liu, ZS; Wang, YX, 2021) |
| "Hyperkalemia is a common electrolyte abnormality in chronic kidney disease (CKD)." | ( Haga, R; Kado, M; Mori, D; Nagatoya, K; Namiki, Y; Nomi, H; Sugimachi, A; Tamai, S; Yamauchi, A, 2022) |
| "Hyperkalemia is a common electrolyte disorder in hospitalized patients; however, the clinical usefulness of administering patiromer for reduction of serum potassium levels in this setting is unknown." | ( Di Palo, KE; Goriacko, P; Sinnett, MJ, 2022) |
| "Hyperkalemia is commonly observed in renal transplant recipients, and it is dose-dependent." | ( AbdelMonem, M; Abo Atya, H; Adel, M; Al-Otaibi, T; Dahab, M; Elserwy, N; Gheith, OA; Nagib, AM; Sobhy, I, 2022) |
| "Hyperkalemia is a potentially fatal complication requiring prompt diagnosis and management." | ( Jain, A; Pourafshar, N; Saleh-Anaraki, K; Wilcox, CS, 2022) |
| "Hyperkalemia is associated with increased morbidity and mortality in patients with chronic kidney disease (CKD)." | ( Fischer, B; Serra, A; Telser, H, 2022) |
| "Hyperkalemia is associated with kidney function decline in patients with non-dialysis dependent chronic kidney disease, but this relationship is unclear for residual kidney function (RKF) among hemodialysis (HD) patients." | ( Arif, Y; Edward, A; Hanna, RM; Hsiung, JT; Kalantar-Zadeh, K; Kovesdy, CP; Lau, WL; Lee, Y; Obi, Y; Streja, E; Wenziger, C, 2022) |
| "Hyperkalemia is associated with a decline in RKF amongst incident HD patients." | ( Arif, Y; Edward, A; Hanna, RM; Hsiung, JT; Kalantar-Zadeh, K; Kovesdy, CP; Lau, WL; Lee, Y; Obi, Y; Streja, E; Wenziger, C, 2022) |
| "Hyperkalemia is a common complication in cardiorenal patients treated with agents interfering with renal potassium (K+) excretion." | ( Artinger, K; Avian, A; Belić, K; Bischof, H; Blass, S; Burgstaller, S; Deak, AT; Eller, K; Graier, WF; Kirsch, AH; Malli, R; Meissl, AM; Niedrist, T; Rechberger, B; Rosenkranz, AR, 2023) |
| "Hyperkalemia is a common yet dangerous phenomenon in patients with chronic kidney disease (CKD)." | ( Beugelink, L; de Groot, DM; van Etten, RW, 2022) |
| "The cause of hyperkalemia is frequently iatrogenic." | ( Appelman-Dijkstra, NM; den Exter, PL; Koopman, JJEB; van der Heiden, W, 2022) |
| "Hyperkalemia is an electrolyte disorder requiring medical attention because it can cause cardiac arrhythmias." | ( de Man, RA; Gritter, M; Hoorn, EJ; Ramakers, C; Rotmans, JI, 2022) |
| "Hyperkalemia is a common and potentially life-threatening electrolyte disorder in maintenance hemodialysis (MHD) patients." | ( Li, P; Li, Y; Liang, X; Wang, P; Xing, X; Yao, L; Zhang, F, 2022) |
| "Hyperkalemia is one prevalent complication in chronic kidney disease and is considered fatal since it potentially causes malignant arrhythmias and mortality." | ( Julario, R; Luke, K; Mulia, EPB; Yofrido, FM, 2022) |
| "Hyperkalemia is a major concern in chronic kidney disease and in end-stage renal disease, representing a predictor of hospitalization and mortality." | ( Ceccanti, C; Cupisti, A; D'Alessandro, C; Guidi, L, 2022) |
| "Predictors of hyperkalemia are yet to be identified." | ( Chen, J; Chen, P; Jin, L; Luo, S; Mei, Z; Zhou, L, 2022) |
| "Hyperkalemia is associated with increased risks of mortality and adverse clinical outcomes." | ( Kanda, E; Kimura, T; Kohsaka, S; Ma, X; Okada, M; Okami, S; Shirakawa, K; Yajima, T, 2022) |
| "Hyperkalemia is a common electrolyte abnormality with characteristic electrocardiogram changes." | ( Deflorio, P; Dockery, S; Dupré, A; Murray, BP, 2023) |
| "Hyperkalemia is a common electrolyte abnormality with characteristic electrocardiogram changes." | ( Deflorio, P; Dockery, S; Dupré, A; Murray, BP, 2023) |
| "Hyperkalemia is one of the more common acute life-threatening metabolic emergencies." | ( Hoang, B; Juarez-Vela, R; Kuo, DC; Mesbah, H; Pappal, R; Peacock, FW; Rafique, Z; Szarpak, L, 2022) |
| "Hyperkalemia is one of the more common acute life-threatening metabolic emergencies." | ( Hoang, B; Juarez-Vela, R; Kuo, DC; Mesbah, H; Pappal, R; Peacock, FW; Rafique, Z; Szarpak, L, 2022) |
| "Hyperkalemia is associated with increased healthcare resource utilization (HRU)." | ( Agiro, A; Betts, KA; Brahmbhatt, YG; Cook, EE; Lemus Wirtz, E; Mu, F; Pollack, CV; Young, JA, 2023) |
| "Hyperkalemia is a common complication of chronic kidney disease (CKD), diabetes mellitus (DM), and heart failure (HF) that can lead to severe arrhythmias and sudden death and is associated with a higher risk of mortality." | ( Liu, BC; Liu, H; Lu, Y, 2023) |
| "The prevalence of hyperkalemia is particularly high in Chinese patients with chronic kidney disease and heart failure." | ( Liu, BC; Liu, H; Lu, Y, 2023) |
| "Concern about hyperkalemia is thought to contribute to this lack of evidence-based therapy." | ( Johnson, M; McMahon, G; Morrison, FJ; Su, M; Turchin, A, 2023) |
| "Hyperkalemia is a common complication of RAASi therapy and is associated with an increased risk of multiple adverse outcomes." | ( Johnson, M; McMahon, G; Morrison, FJ; Su, M; Turchin, A, 2023) |
| "Severe hyperkalemia is a common and life-threatening problem presenting to the emergency department." | ( Arani, N; Wechsler, AH, 2023) |
| "Unknown origin hyperkalemia is a life-threatening complication that can occur during general anesthesia." | ( Hofmeister, E; Nickell, J; Sanchez, A; Smith, CK; Tisotti, T, 2023) |
| "Hyperkalemia is caused by impaired renal excretion, transcellular shifts, or increased potassium intake." | ( Kim, MJ; Knobloch, GK; Valerio, C, 2023) |
| "Hyperkalemia is a frequent complication in patients with chronic kidney disease (CKD) or heart failure (HF) and associated with neuromuscular manifestations, changes in the electrocardiogram, and increased risk of mortality." | ( AbdulShafy, M; Al-Ghamdi, S; Al-Rowaie, F; AlJoburi, H; AlMogbel, O; AlSahow, A; Attallah, N; Bader, F; Hassan, M; Hussein, H; Taha, K; Weir, MR; Zannad, F, 2023) |
| "Hyperkalemia is a life-threatening complication in patients with CKD, as it is associated with adverse cardiovascular and kidney outcomes." | ( Li, R; Tian, R; Zhou, X, 2023) |
| "Untreated chronic hyperkalemia is associated with an increased risk of mortality." | ( Boutin, S; Chen, W; Kovesdy, CP; Patel, S; Pinnell, D; Qualls, J; Rathod, A; Sauer, BC; Tangri, N; Woods, SD, 2023) |
| "Hyperkalemia is a relatively common electrolyte abnormality that in serious cases can lead to life-threatening arrhythmias." | ( Chantzi Christos, D; Hedbäck, T, 2023) |